INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,310 | +57.4% | 825,800 | -6.1% | 0.03% | +85.7% |
Q2 2023 | $9,726 | -31.0% | 879,400 | -16.3% | 0.01% | -26.3% |
Q1 2023 | $14,104 | +61.0% | 1,050,200 | +48.3% | 0.02% | +58.3% |
Q4 2022 | $8,762 | -99.9% | 708,300 | -4.2% | 0.01% | -20.0% |
Q3 2022 | $10,312,000 | +89.8% | 739,200 | +87.9% | 0.02% | +150.0% |
Q2 2022 | $5,433,000 | +55.2% | 393,400 | +82.8% | 0.01% | +50.0% |
Q1 2022 | $3,501,000 | -11.8% | 215,200 | -11.6% | 0.00% | -20.0% |
Q4 2021 | $3,968,000 | +33.9% | 243,569 | +22.0% | 0.01% | +25.0% |
Q3 2021 | $2,964,000 | +260.6% | 199,600 | +460.7% | 0.00% | +300.0% |
Q1 2021 | $822,000 | -92.4% | 35,600 | -91.9% | 0.00% | -91.7% |
Q4 2020 | $10,794,000 | +6.4% | 437,000 | +78.6% | 0.01% | +20.0% |
Q3 2020 | $10,145,000 | -33.9% | 244,700 | -23.6% | 0.01% | -23.1% |
Q2 2020 | $15,341,000 | -20.5% | 320,200 | +4.5% | 0.01% | -31.6% |
Q1 2020 | $19,291,000 | +68.8% | 306,400 | +232.3% | 0.02% | +111.1% |
Q4 2019 | $11,425,000 | +1751.7% | 92,200 | +1707.8% | 0.01% | +800.0% |
Q2 2017 | $617,000 | -94.0% | 5,100 | -91.7% | 0.00% | -95.8% |
Q3 2015 | $10,217,000 | -31.1% | 61,600 | +0.3% | 0.02% | -29.4% |
Q2 2015 | $14,821,000 | +591.3% | 61,400 | +844.6% | 0.03% | +580.0% |
Q1 2014 | $2,144,000 | – | 6,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |